MA-DESKTOP-METAL
18.6.2024 14:31:33 CEST | Business Wire | Press release
Desktop Metal (NYSE: DM), a global leader in Additive Manufacturing 2.0 technologies for mass production, today announced that platinum is now a customer-qualified material on the Production System™ P-1 with a specialty powder developed by Legor.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618795152/en/
Platinum jewelry designs 3D printed by Legor on a Desktop Metal Production System P-1 are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles. The Legor parts to be shown include including a classic wedding band, a gemstone ring, and an intricate leaf earring. (Photo: Business Wire)
Legor is a full-service jewelry manufacturing solutions provider, and the company’s Powmet line of certified ultra-pure metal powders is produced for use with both laser and binder jet 3D printing systems.
“The qualification of Legor’s Powmet platinum on the Production System P-1 is another major milestone for binder jet 3D printing for the jewelry, watchmaking, and luxury goods industry,” said Ric Fulop, Founder and CEO of Desktop Metal. “Platinum is known to be a challenging-to-process material in the jewelry industry because of its high hardness and melting point. Our binder jet 3D printing process simplifies platinum production and enables all-new, once-impossible designs.”
”Legor is currently experiencing significant market interest in 3D printing technology, specifically in binder jet technology,” added Fabio Di Falco, Marketing and Customer Support Manager at Legor. “This has led us to address a variety of requests, ranging from prototyping to small batch production, as well as larger production runs. Thanks to binder jet 3D printing technology, designers can finally imagine and create objects that are currently unproducible with other technologies, thus expanding the boundaries of creativity to shape the future. At Legor, we are committed to becoming catalysts for innovation and promoting technology we are convinced represents a crucial turning point for our industry.”
Platinum jewelry designs 3D printed by Legor — including a classic wedding band, a gemstone ring, and an intricate leaf earring — are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles.
Binder Jet 3D Printing for Jewelry and Watchmaking
In 2023, Legor invested in a Desktop Metal Production System P-1, a high-speed, 1-liter binder jet 3D printing system featuring Single Pass Jetting (SPJ) technology. The experienced jewelry manufacturer notes that binder jet 3D printing technology offers several benefits over traditional manufacturing methods and other forms of 3D printing for jewelry production including:
- Rapid production of jewelry samples without molds or printing supports
- All-new design freedom for fast, affordable production of hollow, interlinked, intricate, and mass customized designs
- Elimination of processing steps associated with jewelry designs, such as welding
- Simplified production of materials that are difficult to work with, such as platinum, which often requires special tools
- Low waste production that is eco-friendly and uses only the necessary amount of metal needed to create the design
Legor’s Di Falco noted that sustainability is an important feature of binder jet 3D printing technology for the jewelry industry and Legor specifically.
“Binder jet 3D printing technology represents a significant step toward more sustainable production,” he noted, “enabling energy efficiency, and reducing the amount of material used. Indeed, binder jetting uses exactly the amount of material necessary to create an object, drastically reducing waste. The metal powder not used in the process can be reused, reducing the need for new raw materials and the risks associated with metal extraction. At Legor, we advocate for 3D printing as a responsible production approach that also considers the planet and people.”
A video by Legor showing the benefits of binder jetting platinum jewelry can be viewed at https://legor.com/en/prodotto/platinum-3d-printing/.
For more information about binder jetting jewelry with DM technologies, visit TeamDM.com/jewelry.
About Desktop Metal
Desktop Metal (NYSE:DM) is driving Additive Manufacturing 2.0, a new era of on-demand, digital mass production of industrial, medical, and consumer products. Our innovative 3D printers, materials, and software deliver the speed, cost, and part quality required for this transformation. We’re the original inventors and world leaders of the 3D printing methods we believe will empower this shift, binder jetting and digital light processing. Today, our systems print metal, polymer, sand and other ceramics, as well as foam and recycled wood. Manufacturers use our technology worldwide to save time and money, reduce waste, increase flexibility, and produce designs that solve the world’s toughest problems and enable once-impossible innovations. Learn more about Desktop Metal and our #TeamDM brands at www.desktopmetal.com.
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in these communications, including statements regarding Desktop Metal’s future results of operations and financial position, financial targets, business strategy, and plans and objectives for future operations, are forward-looking statements. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: risks associated with the integration of the business and operations of acquired businesses; Desktop Metals’ ability to realize the benefits from cost saving measures; supply and logistics disruptions, including shortages and delays. For more information about risks and uncertainties that may impact Desktop Metal’s business, financial condition, results of operations and prospects generally, please refer to Desktop Metal’s reports filed with the SEC, including without limitation the “Risk Factors” and/or other information included in the Form 10-Q filed with the SEC on August 3, 2023, and such other reports as Desktop Metal has filed or may file with the SEC from time to time. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618795152/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release
Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
